tiprankstipranks
Trending News
More News >
Iradimed Corp (IRMD)
:IRMD
US Market
Advertisement

Iradimed (IRMD) Earnings Dates, Call Summary & Reports

Compare
169 Followers

Earnings Data

Report Date
Jan 29, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.48
Last Year’s EPS
0.44
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 03, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth and positive outlook for new product launches, with raised financial guidance and healthy cash reserves. However, higher operating expenses and regulatory challenges for international expansion were noted.
Company Guidance
During the IRADIMED CORPORATION Third Quarter 2025 Financial Results Conference Call, the company provided updated guidance for future performance, highlighting robust growth metrics. For Q3 2025, IRADIMED reported a 16% increase in revenue year-over-year, reaching $21.2 million, with a gross profit margin of 78%. The company anticipates Q4 2025 revenue between $21.4 million and $22.4 million, and GAAP diluted earnings per share ranging from $0.43 to $0.47. For the full year 2025, revenue guidance was raised to $82.5 million to $83.5 million, with GAAP diluted EPS expected between $1.68 and $1.72. Key growth drivers included a 20% increase in MRI IV pump sales and a 16% rise in MRI patient monitor shipments. The planned rollout of the new 3870 MRI IV pump, expected to drive significant revenue growth, will include a price increase of 10% to 14%. With strategic focus on replacement opportunities, the company aims to achieve a $50 million revenue run rate in pumps alone, with additional growth anticipated from disposables, maintenance, and international sales.
17th Consecutive Quarter of Record Revenue
IRADIMED achieved its 17th consecutive quarter of record revenue, with Q3 2025 revenue surpassing Q3 2024 by 16%, reaching $21.2 million.
Strong Growth in Product Lines
The 3860 MRI IV pump grew 20% year-over-year in Q3, and MRI patient monitor shipments grew by 16%. Gross profit margin was 78%, with earnings per share increasing by 8% from Q3 2024.
Positive Outlook for 3870 MRI IV Pump
The new 3870 MRI IV pump, expected to increase revenue significantly, is anticipated to penetrate new markets and replace older models. A price increase of 10% to 14% is planned, with a target to sell 2,000 channels annually.
Raised Financial Guidance for 2025
Revenue guidance for 2025 increased to $82.5 million to $83.5 million, with GAAP EPS expected to be $1.68 to $1.72, up from previous estimates.
Strong Financials and Cash Position
Net income increased by 12% to $5.6 million, with cash and cash equivalents rising to $56.5 million. Free cash flow was $5.7 million for the quarter.

Iradimed (IRMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

IRMD Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jan 29, 2026
2025 (Q4)
0.48 / -
0.44
Nov 03, 2025
2025 (Q3)
0.46 / 0.47
0.439.30% (+0.04)
Aug 01, 2025
2025 (Q2)
0.43 / 0.49
0.4216.67% (+0.07)
May 05, 2025
2025 (Q1)
0.41 / 0.42
0.3616.67% (+0.06)
Feb 13, 2025
2024 (Q4)
0.44 / 0.44
0.3912.82% (+0.05)
Oct 31, 2024
2024 (Q3)
0.41 / 0.43
0.430.00% (0.00)
Aug 01, 2024
2024 (Q2)
0.36 / 0.42
0.3616.67% (+0.06)
May 02, 2024
2024 (Q1)
0.34 / 0.36
0.320.00% (+0.06)
Feb 08, 2024
2023 (Q4)
0.38 / 0.39
0.3221.88% (+0.07)
Nov 03, 2023
2023 (Q3)
0.36 / 0.43
0.2948.28% (+0.14)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

IRMD Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 03, 2025
$76.66$83.94+9.50%
Aug 01, 2025
$58.08$65.88+13.43%
May 05, 2025
$53.07$51.90-2.20%
Feb 13, 2025
$59.84$54.82-8.39%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Iradimed Corp (IRMD) report earnings?
Iradimed Corp (IRMD) is schdueled to report earning on Jan 29, 2026, Before Open (Confirmed).
    What is Iradimed Corp (IRMD) earnings time?
    Iradimed Corp (IRMD) earnings time is at Jan 29, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is IRMD EPS forecast?
          IRMD EPS forecast for the fiscal quarter 2025 (Q4) is 0.48.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis